Waddick, Christopher James — Insider Profile

Insider Profile

Waddick, Christopher James

$CRDL

Companies Filed At

Open-Market Buys (2yr)

$50K

Buy Value (2yr, open-market)

Dec 30, 2025

Most Recent Trade

Credibility
Score

Hit Rate

-20.5%

Avg 90d Return

-11.9%

Median 90d Return

Evaluated Trades

-2.2%

Best Trade

-51.8%

Worst Trade

Hit rate and returns are based on 7 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Dec 30, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	39,692	—	—	45
Dec 03, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	250,000	$1.40	$350K	45
Sep 30, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	23,900	—	—	45
Dec 16, 2024	$CRDL Cardiol Therapeutics Inc	—	Open Market	Buy	25,900	$1.92	$50K	45
Jul 10, 2024	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	285,000	—	—	45
Dec 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	8,185	—	—	45
Dec 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	8,185	—	—	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	555,706	$1.41	$784K	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	555,706	$1.41	$784K	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Expiry	Sell	500,000	—	—	45

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Signal scores reflect the company's current score, not the score at time of trade.